Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study (COMP)
The research question is if there is a dose-response relationship between blood biomarkers for articular cartilage and the magnitude of physiological load. To investigate this load induced biomarker change, the participants will complete a 30-minute walking test under three loading conditions: A: 80%, B: 100% C: 120% of their respective bodyweight (Fig. 1).
The main biomarker we are interested in is called cartilage oligomeric matrix protein (COMP). Serum COMP levels are increased immediately after 30-min running but there is no dose-response relationship shown yet.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
The current state of research in the field and of our own research clearly shows that the in vivo mechanobiology of articular cartilage is poorly understood. Previous results of changes in cartilage biomarker concentrations after ambulatory exercise raise the following question:
Do load-induced changes in blood biomarkers for articular cartilage (COMP) depend on the physiological load magnitude? To generate initial data for answering this question, we will establish the experimental framework to systematically study the in vivo mechanobiology of human articular cartilage to address the following aims.
- To obtain pilot data for investigating the in vivo dose-response relationship of weight-bearing and blood levels of mechanosensitive biomarker of articular cartilage using controlled load- bearing as experimental paradigm.
- To provide pilot data for comparing ambulatory biomechanics between the controlled load- bearing conditions.
The experimental setting consists of a 30-minutes walking stress test under three loading conditions: A: 80 %, B: 100% and C: 120% bodyweight. Unloading will be achieved through an unloading system and additional loading with an adjustable weight vest. Before and after the walking stress test, venous blood samples will be taken at five time points. The biomarker concentration is measured with a commercial available enzyme-linked immunosorbent assay (ELISA).
Hypothesis Our working hypothesis is that there is a dose-response relationship between the temporarily increased or decreased load and the load-induced change in COMP level in the blood serum. We assume that serum COMP concentration increases with increasing accumulated load on the knee cartilage simulated through the three different loading conditions.
Design The design of the pilot study is a controlled multimodal data collection (biological, biomechanical) with block randomization. Specifically, we will collect blood samples and biomechanical (kinematic and pressure) data. We will determine the relationship between the serum blood concentration and the biomechanical data.
Because this is a cross-over study, all participants will perform the same three walking stress tests but in random order. Each participant of the study will be tested for 2.5 hours on 3 separate days.
Method In this experiment, we will test 24 healthy participants (12 male, 12 female) on 3 test days under three different loading conditions in a randomized block design. On each test day, participants will complete walking stress test for 30-minutes with A: 80%, B: 100% and C: 120% of their bodyweight. Through the modified bodyweight we generate higher or lower forces on the knee cartilage, which should affect the COMP concentration in the blood serum.
To measure the change in serum COMP concentration, blood samples will be taken at five time points before and after the walking stress test. The blood samples are taken by a study nurse. For the venipuncture, a thin, sterile, disposable vein catheter is placed in the antecubital vein. The catheter stays in the vein for the entire 2.5 hours of the experiment. Blood samples will be collected and allowed to clot for 30-minutes. Serum will be separated and frozen in aliquots to -20°C within 1 hour of collection and then transferred for storage at -80°C until assayed. Serum biomarker concentrations will be determined using commercial ELISAs.
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Basel Stadt
-
Basel, Basel Stadt, Sveits, 4031
- University Hospital Basel
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age between 18 and 30 years
- being physically active (> 2/week)
- body mass index (BMI) <30 kg/m2
Exclusion Criteria:
- previous knee injury
- neuromuscular condition affecting gait
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Ingen inngripen: Normal load
Healthy subjects walking for 30 minutes on a treadmill with normal body weight
|
|
|
Eksperimentell: Increased load
Healthy subjects walking for 30 minutes on a treadmill with 20% additional body weight
|
Participants walk with 120% body weight achieved with a weight vest
|
|
Eksperimentell: Reduced load
Healthy subjects walking for 30 minutes on a treadmill with 20% lower body weight
|
Participants walk with 80% body weight achieved by a dynamic unloading system
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Load-induced serum Cartilage Oligomeric Matrix Protein concentration
Tidsramme: 3 hours
|
Change in serum concentration during 30-minute walking exercise determined by commercial ELISA 30 min before to 2 hours after 30-minute walking exercise
|
3 hours
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall ground reaction force impulse
Tidsramme: 30 minutes
|
Area under the ground reaction curve multiplied by number of steps taken during 30-minute walking exercise
|
30 minutes
|
|
Dynamic range of motion lower extremity joints
Tidsramme: 30 minutes
|
Min to max joint angles (ankle, knee, hip) measured using RehaGait (inertial measurement units)
|
30 minutes
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Age
Tidsramme: At enrollment
|
Age in years
|
At enrollment
|
|
Sex
Tidsramme: At enrollment
|
male or female
|
At enrollment
|
|
Body mass index
Tidsramme: At enrollment
|
BMI in kg/m2
|
At enrollment
|
|
Knee function
Tidsramme: At enrollment
|
Knee Osteoarthritis Outcome Score measured by questionnaire (best score: 100 - no limitations; worst score: 0)
|
At enrollment
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Samarbeidspartnere
Samarbeidspartnere
Etterforskere
Etterforskere
- Hovedetterforsker: Annegret Muendermann, PhD, University Hospital, Basel, Switzerland
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Faktiske)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
Andre studie-ID-numre
- 2017-01006
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Sunn
-
NCT06551870RekrutteringHealthy People-programmer
-
NCT05275140FullførtHealthy People-programmer
-
NCT05826314Aktiv, ikke rekrutterendeHealthy People-programmer
-
NCT06955689FullførtHealthy People-programmer | Forebygging og kontroll
-
NCT07513766RekrutteringHealthy Controls Group - alders- og kjønnsmatchet | Repeterende negativ tenkning
-
NCT02585791AvsluttetHealthy Lifetime Ikke-røykere
-
NCT01886339FullførtHealthy People-programmer
-
NCT06880640RekrutteringHealthy Controls Group - alders- og kjønnsmatchet | Borderline personlighetsforstyrrelse (BPD)
Kliniske studier på Increased load
-
NCT07450794Har ikke rekruttert ennåAnestesilegearbeidsbelastning
-
NCT07142889Har ikke rekruttert ennåRekonstruksjon av fremre korsbånd | Blodstrømningsbegrensningstrening | Muskelmorfologi | Patella -stilling | Benfunksjon
-
NCT04550013Aktiv, ikke rekrutterendeJumpers kne | Patellar tendinopati
-
NCT03767231Har ikke rekruttert ennå
-
NCT00039741Fullført
-
NCT04014179Fullført
-
NCT02680678FullførtKomplikasjoner; Anestesi, spinal og epidural, under graviditet
-
NCT05951036Fullført